Literature DB >> 29534986

Peri-Procedural Management of Oral Anticoagulants in the DOAC Era.

Geoffrey D Barnes1, Erin Mouland2.   

Abstract

Peri-procedural management of oral anticoagulants can be complex and confusing for many providers. It involves a careful balance of a patient's thromboembolic risk and bleeding risk. For every patient chronically taking an oral anticoagulant who will be undergoing an elective procedure, a four step approach may be considered when creating a plan for the oral anticoagulant. (1) Does the oral anticoagulant need to stop for the procedure? (2) If yes, when should the oral anticoagulant be stopped pre-procedure? (3) Does the patient require a "bridging" parenteral anticoagulant? (4) When should anticoagulation be re-started post procedure? Based on the unique features of warfarin versus the direct oral anticoagulants (DOAC), a unique, personalized plan should be developed and tailored to the individual patient. Anticoagulant specialists, such as anticoagulation clinic pharmacists, may help facilitate this process.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Direct oral anticoagulant (DOAC); Oral anticoagulant; Peri-procedural management; Warfarin

Mesh:

Substances:

Year:  2018        PMID: 29534986      PMCID: PMC5972056          DOI: 10.1016/j.pcad.2018.03.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  26 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

Authors:  David Garcia; John H Alexander; Lars Wallentin; Daniel M Wojdyla; Laine Thomas; Michael Hanna; Sana M Al-Khatib; Paul Dorian; Jack Ansell; Patrick Commerford; Greg Flaker; Fernando Lanas; Dragos Vinereanu; Denis Xavier; Elaine M Hylek; Claes Held; Freek W A Verheugt; Christopher B Granger; Renato D Lopes
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

4.  Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Authors:  Michael Rud Lassen; Alexander Gallus; Gary E Raskob; Graham Pineo; Dalei Chen; Luz Margarita Ramirez
Journal:  N Engl J Med       Date:  2010-12-23       Impact factor: 91.245

5.  Perioperative Management of Dabigatran: A Prospective Cohort Study.

Authors:  Sam Schulman; Marc Carrier; Agnes Y Y Lee; Sudeep Shivakumar; Mark Blostein; Frederick A Spencer; Susan Solymoss; Rebecca Barty; Grace Wang; Nancy Heddle; James D Douketis
Journal:  Circulation       Date:  2015-05-12       Impact factor: 29.690

6.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Authors:  James D Douketis; Alex C Spyropoulos; Scott Kaatz; Richard C Becker; Joseph A Caprini; Andrew S Dunn; David A Garcia; Alan Jacobson; Amir K Jaffer; David F Kong; Sam Schulman; Alexander G G Turpie; Vic Hasselblad; Thomas L Ortel
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

7.  Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).

Authors:  Matthew W Sherwood; James D Douketis; Manesh R Patel; Jonathan P Piccini; Anne S Hellkamp; Yuliya Lokhnygina; Alex C Spyropoulos; Graeme J Hankey; Daniel E Singer; Christopher C Nessel; Kenneth W Mahaffey; Keith A A Fox; Robert M Califf; Richard C Becker
Journal:  Circulation       Date:  2014-02-19       Impact factor: 29.690

8.  Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Authors:  Michael Rud Lassen; Gary E Raskob; Alexander Gallus; Graham Pineo; Dalei Chen; Ronald J Portman
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

9.  Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Authors:  Riccardo Cappato; Francis E Marchlinski; Stefan H Hohnloser; Gerald V Naccarelli; Jim Xiang; David J Wilber; Chang-Sheng Ma; Susanne Hess; Darryl S Wells; George Juang; Johan Vijgen; Burkhard J Hügl; Richard Balasubramaniam; Christian De Chillou; D Wyn Davies; L Eugene Fields; Andrea Natale
Journal:  Eur Heart J       Date:  2015-05-14       Impact factor: 29.983

10.  Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Eric D Peterson; Sunghee Kim; Laine Thomas; Bernard J Gersh; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Matthew W Sherwood; Paul Chang; Jonathan P Piccini; Jack Ansell
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690

View more
  9 in total

1.  Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.

Authors:  Christine Baumgartner; Ivan de Kouchkovsky; Evans Whitaker; Margaret C Fang
Journal:  Am J Med       Date:  2019-01-16       Impact factor: 4.965

2.  Periprocedural Antithrombotic Management from a Patient Perspective: A Qualitative Analysis.

Authors:  Jennifer Acosta; Christopher Graves; Elizabeth Spranger; Jacob Kurlander; Anne E Sales; Geoffrey D Barnes
Journal:  Am J Med       Date:  2018-12-03       Impact factor: 4.965

Review 3.  Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.

Authors:  Ghada A Bawazeer; Hadeel A Alkofide; Aya A Alsharafi; Nada O Babakr; Arwa M Altorkistani; Tarek S Kashour; Michael Miligkos; Khalid M AlFaleh; Lubna A Al-Ansary
Journal:  Cochrane Database Syst Rev       Date:  2021-10-21

4.  Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures.

Authors:  Muhammad Adil Sheikh; Xiaowen Kong; Brian Haymart; Scott Kaatz; Gregory Krol; Jay Kozlowski; Musa Dahu; Mona Ali; Steven Almany; Tina Alexandris-Souphis; Eva Kline-Rogers; James B Froehlich; Geoffrey D Barnes
Journal:  Thromb Res       Date:  2021-04-19       Impact factor: 10.407

5.  Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms.

Authors:  Jinju Choi; Soo-Jeong Cho; Sang-Hoon Na; Ayoung Lee; Jue Lie Kim; Hyunsoo Chung; Sang Gyun Kim
Journal:  Sci Rep       Date:  2021-04-30       Impact factor: 4.379

Review 6.  Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction.

Authors:  Balbir Singh; Paresh Pai; Harish Kumar; Sheeba George; Sandeep Mahapatra; Vineet Garg; G N Gupta; Kiran Makineni; Gaurav Ganeshwala; Pravin Narkhede; Syed M H Naqvi; Kumar Gaurav; Mohammed Y K Hukkeri
Journal:  Cardiol Ther       Date:  2022-02-08

7.  Intracranial hemorrhage associated with direct oral anticoagulant after clipping for an unruptured cerebral aneurysm: A report of two cases.

Authors:  Takahiro Koji; Yoshitaka Kubo; Yoshiyasu Matsumoto; Yosuke Akamatsu; Kohei Chida; Hiroshi Kashimura; Kuniaki Ogasawara
Journal:  Surg Neurol Int       Date:  2022-03-25

Review 8.  Perioperative Considerations for Antithrombotic Therapy in Oculofacial Surgery: A Review of Current Evidence and Practice Guidelines.

Authors:  Christian Kim; Margaret L Pfeiffer; Jessica R Chang; Michael A Burnstine
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-01-11       Impact factor: 2.011

9.  Fat Necrosis Following Application of a Tourniquet During Total Knee Arthroplasty.

Authors:  Kim Sammut; Raymond Gatt; Kieran Chircop
Journal:  Arthroplast Today       Date:  2022-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.